We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 949 results
  1. Genomics in Treatment Development

    The Human Genome Project mapped the 3 billion base pairs in the human genome, which ushered in a new generation of genomically focused treatment...
    Yogesh Dwivedi, Richard C. Shelton in Drug Development in Psychiatry
    Chapter 2023
  2. Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling

    Magnus Ingelman-Sundberg, Daniel W. Nebert, Volker M. Lauschke in Human Genomics
    Article Open access 24 November 2023
  3. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy

    Abstract

    Considering the variability in individual responses to opioids and the growing concerns about opioid addiction, prescribing opioids for...

    Kai-Uwe Lewandrowski, Alireza Sharafshah, ... Franklin Todd Wetzel in Cellular and Molecular Neurobiology
    Article Open access 27 May 2024
  4. In-silico mining to glean SNPs of pharmaco-clinical importance: an investigation with reference to the Indian populated SNPs

    Drugs pharmacology is defined by pharmacokinetics and pharmacodynamics and both of them are affected by genetic variability. Genetic variability...

    Anamika Yadav, Shivani Srivastava, ... Pramod Katara in In Silico Pharmacology
    Article 19 July 2023
  5. The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats

    Background and Objectives

    AT-533 is a novel heat shock protein 90 inhibitor, which exhibits various biological activities in vitro and in vivo....

    Yanting Wu, Menghe Li, ... Yifei Wang in European Journal of Drug Metabolism and Pharmacokinetics
    Article 09 February 2022
  6. Pharmacogenetics: A New Approach for the Selection of the Right Drug

    Pharmacogenetics is the study of genes and the way an individual will respond to a particular drug. It is an advanced branch of medicine where the...
    Hitesh Malhotra, Abhishek Dabra, ... Rupesh Gautam in Recent Advances in Pharmaceutical Innovation and Research
    Chapter 2023
  7. Drug Interactions

    Drug-drug interactions (DDIs) are considered as change of drug-related effects due to the simultaneous administration of another drug. As a...
    Reference work entry 2021
  8. Drug Interactions

    Drug-drug interactions (DDIs) are considered as change of drug-related effects due to the simultaneous administration of another drug. As a...
    Living reference work entry 2021
  9. Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs

    Evidence from preclinical and clinical studies demonstrate that pregnancy is a physiological state capable of modifying drug disposition. Factors...
    Pablo Torres-Vergara, Robin Rivera, ... Jeffrey Penny in Advances in Maternal-Fetal Biomedicine
    Chapter 2023
  10. Significance of Stability and Pharmacokinetic Issues in Traditional Medicine

    Herbal medicine has become the backbone of the traditional medicine in recent years. There is an increase in demand in the global market and...
    Lavanya Bolla, Navitha Reddy Gangireddy, ... Satheeshkumar Nanjappan in Evidence Based Validation of Traditional Medicines
    Chapter 2021
  11. Frequencies of CYP2D6 genetic polymorphisms in Arab populations

    CYP2D6 is a key drug-metabolizing enzyme implicated in the biotransformation of approximately 25% of currently prescribed drugs. Interindividual and...

    Mousa Alali, Wouroud Ismail Al-khalil, ... Lama A. Youssef in Human Genomics
    Article Open access 05 February 2022
  12. An Insight into Herb Interactions: Clinical Evidence-Based Overview

    Medicines are used for betterment of human health, and huge number of human population uses medicines for the same. But the desired effects of these...
    Namdeo Ajay Gajanan, Bandekar Sparsha Suresh in Evidence Based Validation of Traditional Medicines
    Chapter 2021
  13. Eighth pharmacologic-historical forum

    Scope, historical overview and perspectives

    Athineos Philippu, Department of Pharmacology and Toxicology, University of Innsbruck, Austria

    ...
    Athineos Philippu, Helmut Greim, ... Ivar von Kügelgen in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 06 July 2022
  14. Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib

    Purpose

    This study implements a physiologically based pharmacokinetic (PBPK) modelling approach to predict the effect of hydrastine and berberine, two...

    Jeffry Adiwidjaja, Alan V. Boddy, Andrew J. McLachlan in European Journal of Clinical Pharmacology
    Article 20 January 2022
  15. Toxicodynamic Tests

    Toxicodynamic testing is aimed at the elucidation of adverse effects of chemicals including understanding of their mode of action. In many cases, the...
    Alexander Cartus, Dieter Schrenk in Regulatory Toxicology
    Reference work entry 2021
  16. Toxicodynamic Tests

    Toxicodynamic testing is aimed at the elucidation of adverse effects of chemicals including understanding of their mode of action. In many cases, the...
    Alexander Cartus, Dieter Schrenk in Regulatory Toxicology
    Living reference work entry 2021
  17. Regulation of Neurogenesis by Organic Cation Transporters: Potential Therapeutic Implications

    Neurogenesis is the process by which new neurons are generated from neural stem cells (NSCs), which are cells that have the ability to proliferate...
    Chapter 2021
  18. A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations

    Background and Objectives

    Hepatic drug metabolism is a key influence on the efficacy and safety of medicines from both chemical and natural product...

    Artitaya Thiengsusuk, Kanyarat Boonprasert, Kesara Na-Bangchang in European Journal of Drug Metabolism and Pharmacokinetics
    Article 02 November 2019
  19. Crohn’s disease in endoscopic remission, obesity, and cases of high genetic risk demonstrate overlap** shifts in the colonic mucosal-luminal interface microbiome

    Background

    Crohn’s disease (CD) patients demonstrate distinct intestinal microbial compositions and metabolic characteristics compared to unaffected...

    Jonathan P. Jacobs, Maryam Goudarzi, ... Jonathan Braun in Genome Medicine
    Article Open access 15 August 2022
  20. Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists

    Over the past decade, pharmacogenetics (PGx) became an essential tool for personalized medicine although its clinical implementation is still...

    Ahmed Edris, Anna Vanoverschelde, ... Lies Lahousse in The Pharmacogenomics Journal
    Article 26 August 2020
Did you find what you were looking for? Share feedback.